Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Jesús María
Prieto Valtueña
Researcher to 2014
Publications by the researcher in collaboration with Jesús María Prieto Valtueña (204)
2020
-
Brain ventricular enlargement in human and murine acute intermittent porphyria
Human molecular genetics, Vol. 29, Núm. 19, pp. 3211-3223
-
Identifying differentially expressed micrornas, target genes, and key pathways deregulated in patients with liver diseases
International Journal of Molecular Sciences, Vol. 21, Núm. 19, pp. 1-16
2019
-
La clínica y el laboratorio: interpretación de análisis y pruebas funcionales, exploración de los síndromes, cuadro biológico de las enfermedades
Elsevier
-
Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses
Molecular Therapy, Vol. 27, Núm. 11, pp. 1892-1905
-
The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells
Cell Death and Disease, Vol. 10, Núm. 1
2017
-
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: Development of an FGF19-based chimeric molecule to promote fatty liver regeneration
Gut, Vol. 66, Núm. 10, pp. 1818-1828
-
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
Translational Research, Vol. 188, pp. 80-91.e2
-
X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver
Gastroenterology, Vol. 152, Núm. 5, pp. 1203-1216.e15
2016
-
Factors related to increased resting energy expenditure in men with liver cirrhosis
European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 2, pp. 139-145
-
Insulin-like growth factor I (IGF-I) expressed from an AAV1 vector leads to a complete reversion of liver cirrhosis in rats
PLoS ONE, Vol. 11, Núm. 9
-
Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria
Journal of Hepatology, Vol. 65, Núm. 4, pp. 776-783
-
Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression
Oncogene, Vol. 35, Núm. 36, pp. 4719-4729
-
Transient expression of transgenic IL-12 in mouse liver triggers unremitting inflammation mimicking human autoimmune hepatitis
Journal of Immunology, Vol. 197, Núm. 6, pp. 2145-2156
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006
-
La clínica y el laboratorio: interpretación de análisis y pruebas funcionales, exploración de los síndromes, cuadro biológico de las enfermedades
Elsevier Masson
-
Matrix Metalloproteinase 10 Contributes To Hepatocarcinogenesis in a Novel Crosstalk With the Stromal Derived Factor 1/C-X-C Chemokine Receptor 4 Axis
Hepatology, Vol. 62, Núm. 1, pp. 166-178
2014
-
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
Journal of Hepatology, Vol. 60, Núm. 5, pp. 1017-1025
-
Comparación de las sondas M y XL para estimar la rigidez hepática por medio de elastografía de transición
Gastroenterologia y Hepatologia, Vol. 37, Núm. 4, pp. 233-239
-
Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair
Liver International, Vol. 34, Núm. 7
-
Splicing regulator SLU7 is essential for maintaining liver homeostasis
Journal of Clinical Investigation, Vol. 124, Núm. 7, pp. 2909-2920